Before organoids, before Cortical Labs, before anyone called biology 'programmable' — Itzhak Bentov was already describing the human body as a computational system with a clock speed, a data format, and a boot sequence.
China just approved the world's first commercial invasive BCI. This isn't a research milestone — it's a geopolitical opening move.
China just commercialized the world's first invasive BCI. While America runs trials, Beijing is implanting devices in hospitals — and building an entire ecosystem around them.
When AI intelligence becomes a commodity, energy efficiency is the only moat left. The companies that win the next decade will own proprietary wetware — not better software.
From John C. Lilly's 1968 vision of the brain as programmable hardware to Cortical Labs' $35,000 CL1, biocomputing has crossed from philosophy into product. Here's how we got here.
Meta just open-sourced the most detailed virtual brain model ever built. It won't replace living neurons — but it could be the fastest path to making them work.
You can now buy a computer powered by living human brain cells or rent organoids in the cloud. We map the full 2026 landscape—from wetware processors to Neuralink trials and programmable cell therapies.
The real frontier of biocomputing isn't DNA — it's the proteome. Here's why intelligent organoids could crack the bottleneck and make drug discovery 100x faster.
Every year, hundreds of thousands of people are told their cancer has no known origin. For decades, medicine had no answer. Now, a deep-learning model trained on 57,000 cytology images may change that forever.